Alessio Fasano, MD, director of the MGHfC’s Center for Celiac Research and Treatment, was featured in two top UK news outlets this summer.
The new MGH Center for Cancer Immunology aims to develop novel therapies that will enable the immune system to kill cancer cells.
The Phillips Society marked the 10th anniversary of its luncheons to celebrate members’ generosity and the profound impact of estate and endowment giving.
With federal funding for research uncertain, the director of the MGH Research Institute discusses alternative ways to provide sustainable and rewarding careers for the next generation of scientists.
MGH researchers have developed a smartphone device that can diagnose cancer and, in the process, reduce patients’ anxiety and improve access to care.
With support from Agilent Technologies, MGH researcher Robert Gerszten, MD, is tracking blood changes to help predict who needs early treatment for heart disease and diabetes.
Mass General team creates smartphone technology to obtain accurate information about penicillin allergies.
Biogen Foundation and the Cleary family have committed nearly half the funds needed to establish an endowed chair honoring former Neurology Chief Anne B. Young, MD, PhD.
The FDA approves the second phase of Dr. Denise Faustman’s clinical testing of a type 1 diabetes vaccine, an exciting next step in her pursuit of a therapy to reverse the disease.
After surviving a catastrophic cardiac event, Chris Toomey pays his luck forward by funding aortic dissection research at Mass General’s Thoracic Aortic Center.